DK1100499T3 - Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse - Google Patents

Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse

Info

Publication number
DK1100499T3
DK1100499T3 DK99922459T DK99922459T DK1100499T3 DK 1100499 T3 DK1100499 T3 DK 1100499T3 DK 99922459 T DK99922459 T DK 99922459T DK 99922459 T DK99922459 T DK 99922459T DK 1100499 T3 DK1100499 T3 DK 1100499T3
Authority
DK
Denmark
Prior art keywords
eletriptan
prevention
migraine recurrence
migraine
recurrence
Prior art date
Application number
DK99922459T
Other languages
English (en)
Inventor
Neville Colin Jackson
Stephen Uden
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK1100499T3 publication Critical patent/DK1100499T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99922459T 1998-07-30 1999-06-14 Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse DK1100499T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816556.6A GB9816556D0 (en) 1998-07-30 1998-07-30 Therapy

Publications (1)

Publication Number Publication Date
DK1100499T3 true DK1100499T3 (da) 2004-06-14

Family

ID=10836395

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99922459T DK1100499T3 (da) 1998-07-30 1999-06-14 Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse

Country Status (35)

Country Link
EP (3) EP1100499B1 (da)
JP (1) JP3824863B2 (da)
KR (2) KR100441732B1 (da)
CN (2) CN1522697A (da)
AP (1) AP1402A (da)
AT (1) ATE261304T1 (da)
AU (1) AU3952199A (da)
BG (1) BG65309B1 (da)
BR (1) BR9912588A (da)
CA (1) CA2338901C (da)
CZ (1) CZ2001357A3 (da)
DE (1) DE69915486T2 (da)
DK (1) DK1100499T3 (da)
EA (2) EA200201149A1 (da)
EE (1) EE04703B1 (da)
ES (1) ES2214027T3 (da)
GB (1) GB9816556D0 (da)
GE (2) GEP20063719B (da)
HR (1) HRP20010079A2 (da)
HU (1) HUP0103424A3 (da)
ID (1) ID26996A (da)
IL (1) IL140169A0 (da)
IS (1) IS2253B (da)
NO (1) NO20010489L (da)
NZ (2) NZ508736A (da)
OA (1) OA11576A (da)
PL (1) PL194611B1 (da)
PT (1) PT1100499E (da)
SG (1) SG125910A1 (da)
SK (1) SK1182001A3 (da)
TR (1) TR200100314T2 (da)
TW (2) TWI248362B (da)
UA (1) UA76399C2 (da)
WO (1) WO2000006161A1 (da)
YU (2) YU20303A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
GB9915231D0 (en) * 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
CN1176649C (zh) * 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
WO2004060355A1 (en) * 2002-12-26 2004-07-22 Pozen Inc. Multilayer Dosage Forms Containing NSAIDs and Triptans
JP2006522790A (ja) 2003-04-11 2006-10-05 ファイザー・インク エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
FR2926721B1 (fr) * 2008-01-30 2011-07-22 Philippe Perovitch Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
CA2765866C (en) 2008-06-20 2016-06-21 Alphapharm Pty Ltd Single phase pharmaceutical composition of a 5-ht1 inhibitor and an nsaid
EP2490669B1 (en) * 2009-10-23 2017-01-11 Fortuderm Ltd. Triptans for the treatment of psoriasis
NZ700474A (en) * 2012-04-18 2016-10-28 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
CN104523709A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种含有琥珀酸夫罗曲坦的复方缓释制剂
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL170330B1 (pl) * 1990-10-15 1996-11-29 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5744482A (en) * 1994-10-05 1998-04-28 Eli Lilly And Company Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine
US6255502B1 (en) * 1996-07-11 2001-07-03 Farmarc Nederland B.V. Pharmaceutical composition containing acid addition salt of basic drug
PL337803A1 (en) * 1997-07-03 2000-09-11 Pfizer Pharmaceutic agents containing eletriptane hemisulphate and caffeine
US6514530B2 (en) * 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape

Also Published As

Publication number Publication date
GEP20063719B (en) 2006-01-10
IL140169A0 (en) 2002-02-10
EP1466601A3 (en) 2005-04-13
EE200100061A (et) 2002-06-17
HRP20010079A2 (en) 2002-02-28
ES2214027T3 (es) 2004-09-01
CN1522697A (zh) 2004-08-25
CA2338901C (en) 2008-02-19
JP3824863B2 (ja) 2006-09-20
CZ2001357A3 (cs) 2001-10-17
DE69915486D1 (de) 2004-04-15
EE04703B1 (et) 2006-10-16
EP1466601A2 (en) 2004-10-13
TR200100314T2 (tr) 2001-06-21
TW200300674A (en) 2003-06-16
EP1100499A1 (en) 2001-05-23
YU6401A (sh) 2004-03-12
SK1182001A3 (en) 2001-10-08
OA11576A (en) 2004-07-01
BG105277A (en) 2001-11-30
PL345803A1 (en) 2002-01-02
AU3952199A (en) 2000-02-21
DE69915486T2 (de) 2005-03-03
KR20010079582A (ko) 2001-08-22
BG65309B1 (bg) 2008-01-31
EP1435237A1 (en) 2004-07-07
PT1100499E (pt) 2004-06-30
EA200100089A1 (ru) 2001-08-27
NO20010489L (no) 2001-03-26
GB9816556D0 (en) 1998-09-30
GEP20043157B (en) 2004-01-26
EA004036B1 (ru) 2003-12-25
AP1402A (en) 2005-04-29
CA2338901A1 (en) 2000-02-10
KR100441732B1 (ko) 2004-07-27
UA76399C2 (en) 2006-08-15
NZ508736A (en) 2003-09-26
YU20303A (sh) 2006-08-17
CN1155379C (zh) 2004-06-30
BR9912588A (pt) 2001-05-02
IS2253B (is) 2007-06-15
HK1038198A1 (en) 2002-03-08
HUP0103424A2 (hu) 2002-02-28
PL194611B1 (pl) 2007-06-29
AP2001002056A0 (en) 2001-03-31
ATE261304T1 (de) 2004-03-15
EA200201149A1 (ru) 2003-02-27
HUP0103424A3 (en) 2003-05-28
KR20030078876A (ko) 2003-10-08
EP1100499B1 (en) 2004-03-10
IS5771A (is) 2000-12-15
JP2002521446A (ja) 2002-07-16
TWI248362B (en) 2006-02-01
SG125910A1 (en) 2006-10-30
WO2000006161A1 (en) 2000-02-10
CN1309560A (zh) 2001-08-22
TW537893B (en) 2003-06-21
NZ527625A (en) 2005-01-28
NO20010489D0 (no) 2001-01-29
ID26996A (id) 2001-02-22

Similar Documents

Publication Publication Date Title
FI981132L (fi) Palvelun luvattoman käytön estäminen
DE69932032D1 (de) Inhibitoren der alpha4 vermittelten zelladhäsion
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
ID20637A (id) Metode untuk menghambat pembentukan sulfida biogenik
NO20001979D0 (no) Anvendelse av inhibitorer av renin-angiotensin-systemet
DK1100499T3 (da) Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse
DK199800837A (da) Anlæg til behandling af emner
DK1054868T3 (da) Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi
FI982378A0 (fi) Järjestely kohteen tutkimiseen
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus
NO982014D0 (no) FremgangsmÕte for beregning av varighet av oppkoblinger
DK1500396T3 (da) Reboxetin til behandling af migrænehovedpiner
TR199902015A3 (tr) Aril-sikloheksilamin türevlerinin CNS bozukluklarina karsi kullanilmasi.
SI1100499T1 (en) Use of eletriptan for the prevention of migraine recurrence
DE69905397D1 (de) Selektive inhibitoren des mmp-12
NO20011268D0 (no) Forbindelse til behandling av depresjon
DK1133290T3 (da) Anvendelse af acetylcholinesterase-inhibitorer til behandling af delirier
DK199901871A (da) Fallerør til lås
NO980820L (no) Dusjhode
FI3524U1 (fi) Yhdistelmäkoura
DK199900400U3 (da) System til beskyttelse af træværk
IT1303963B1 (it) Dispositivo per il serraggio di pezzi o simili .
NO970186D0 (no) Varmegjenvinner for dusj
IT1302348B1 (it) Procedimento di inertizzazione di amianti mediante applicazioni dimicroonde.
IT1287349B1 (it) Pertica per il livellamento di superfici intonacate.